Table 1.
Clinical backgrounds and AMH levels in serum and peritoneal fluids.
| Endometriosis | Control | ||
|---|---|---|---|
| Stage* of endometriosis | III | IV | |
| Number of subjects | 30 | 60 | 32 |
| Mean age, years old (range) | 32.4 ± 4.7 | 32.0 ± 6.9 (15–44) |
|
| 31.0 ± 4.4 (24–41) | 33.1 ± 4.7 (21–45) | ||
| Subjects >35 years old | 7 (23%) | 23 (38%) | 12 (38%) |
| Subjects with infertility | 12 (40%) | 42 (70%)† | 14 (44%) |
| Subjects with endometriomas | 26 (87%) | 58 (97%) | NA |
| Mean lesion score by rASRM system (range) | 21.6 ± 6.5 (6–38) | 33.4 ± 11.0 (6–58) | NA |
| Mean adhesion score by rASRM system (range) | 8.3 ± 6.0 (0–28) | 44.7 ± 26.5 (6–96) | NA |
| Mean serum AMH levels, ng/mL (range) | 2.90 ± 2.21 | 3.17 ± 2.93 (0.02–9.82) |
|
| 3.57 ± 2.40 (0.19–9.79) | 2.57 ± 2.05 (0.1–9.91) | ||
| Mean PF AMH levels, ng/mL(range) | 2.15 ± 2.13‡ | 4.40 ± 4.77‡ (0.01–18.2) |
|
| 2.11 ± 1.47 (0.01–5.56) | 2.17 ± 2.41 (0.01–11.4) | ||
Values are expressed as mean ± SD (standard deviation); NA, not applicable; PF, peritoneal fluids.
*
Stage of endometriosis were classified according to the revised ASRM (American Society of Reproductive Medicine) scoring system.
†
P = 0.006 vs. stage III, P = 0.01 vs. control, kai square test.
‡
P = 0.0002, student-t test.